2 completed, 1 recruiting. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow fampridine: new trials by email Literature Review of fampridine trials Research Report on fampridine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 4-aminopyridine Treatment for Nerve Injury 4-Aminopyridine, Placebo - Nerve Injury, Prostate Cancer | Phase 2 / Phase 3 | Recruiting | John Elfar | 70 | 2021-06-05 | 2025-12-17 |
| Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis fampridine, Placebo - Multiple Sclerosis | Phase 3 | Completed | Biogen | 646 | 2014-09-01 | 2017-03-27 |
| Ampyra for Optic Neuritis in Multiple Sclerosis Dalfampridine/Placebo, Placebo/Dalfampridine - Multiple Sclerosis, Optic Neuritis | Phase 2 / Phase 3 | Completed | Washington University School of Medicine | 53 | 2011-05-01 | 2020-01-30 |
Multiple Sclerosis (2) · Erectile Dysfunction (1) · Optic Neuritis (1) · Prostatic Neoplasms (1)
Biogen (1) · John Elfar (1) · Washington University School of Medicine (1)
United States (3) · Bulgaria (1) · Czechia (1) · Finland (1) · Italy (1) · Lithuania (1) · Netherlands (1) · Poland (1) · Russia (1) · Serbia (1) · United Kingdom (1)
John Elfar, MD (1) · Rashid Sayyid, MD (1) · Robert T Naismith, MD (1)